TrumpRx is a government-operated website announced by President Donald Trump, designed to allow Americans to buy prescription medications directly from manufacturers at discounted prices, bypassing insurance and intermediaries like Pharmacy Benefit Managers (PBMs). The initiative aims to reduce drug costs in the U.S. by selling many primary care and some specialty drugs at an average discount of around 50%, with some discounts as high as 85%, especially from Pfizer, which is a key partner in this effort. Pfizer also agreed to supply its medications to Medicaid at "most favored nation" prices—the lowest prices available in comparable countries—and will invest $70 billion in domestic manufacturing and research. The TrumpRx website is expected to launch in 2026 and operates on a direct-to-consumer model where consumers paying with cash may benefit from lower prices, although it may not significantly modify insured patients’ costs due to insurance policies and intermediaries. This program is part of a broader campaign to lower healthcare costs and change international drug pricing dynamics to better benefit American consumers.
